Hong Kong - Novotech, a leading biotech specialist CRO in the Asia-Pacific region, with more than 2,000 staff globally, has joined the GoGive1 campaign, where for every fully vaccinated team member a vaccine is donated to a person in a lower income country.
A recent company-wide survey showed 95% of team members have had at least 1 dose or plan to be vaccinated.
Novotech joined the GoGive1 campaign, backed by the WHO Foundation and GAVI, as part of the company’s COVID-19 safe workplace initiative.
The Novotech workplace policy requires team members who work in the office, visit sites or travel to provide evidence that they have been fully vaccinated.
Novotech CEO John Moller said:
“Providing a safe working environment for staff is a priority for all employers around the world, and at Novotech we have an additional duty to protect the healthcare workers and patients at the sites we visit.
Our COVID-19 vaccination policy supports our objective of reaching full vaccination across the company.
Our approach considers local vaccine availability and rollout, and we are funding vaccinations for Team Members where there is limited government support or to accelerate the vaccination process.
As part of this program, Novotech is donating one vaccine for every fully vaccinated team member, to a lower income country via the WHO and GAVI GoGive1 initiative.”
Novotech’s Chief People Officer, Angela Edwardson said:
“Since vaccines have become available, we have strongly encouraged our Team Members to get vaccinated.
We have overwhelming support for our company policy that employees should be fully vaccinated on their return to the office. Meanwhile our flexible work options will also allow unvaccinated employees to work remotely as we transition.
We look forward to welcoming teams back to the office as restrictions ease across our regions.”
Our key initiatives
- Novotech is funding vaccination for team members in countries that have limited government support, or to accelerate the vaccination process.
- Team members who work in the office, visit sites or travel will need to provide evidence that they have been fully vaccinated or have received a negative test result.
- Policy implementation will be phased and dependent on vaccine rollout and availability in each location
- Novotech’s flexible working options facilitate Team Members to receive their vaccinations during normal working hours
Novotech’s vaccine donation and matching programs
Go Give 1 incentive program
For every fully vaccinated team member, Novotech will donate 1 Vaccine via the GoGive1 program. GoGive1 was created by the WHO Foundation and GAVI (https://www.gavi.org/gavi-covax-amc). Novotech has the potential to contribute over 2,000 vaccinations via this program
Donation Matching Program
In May 2021, Novotech ran a donation matching initiative, matching all employee donations to Care.org, to provide urgent funding to India during the peak of their COVID-19 outbreak.
Media contact
Toyna Chin
About Novotech Novotech-CRO.com
Novotech is a globally recognized full-service clinical research organization (CRO) and scientific advisory company trusted by biotech and small- to mid-sized pharmaceutical companies to guide drug development at every phase.
With a global footprint that includes 30+ offices across the Asia-Pacific region, North America, and Europe and partnerships with 5,000+ trial sites, Novotech provides clients an accelerated path to bring life-changing therapies to market by providing access to key clinical trial destinations and diverse patient populations.
Through its client-centric service model, Novotech seamlessly integrates people, processes, and technologies to deliver customized solutions that accelerate the path to market for life-changing therapies. By adopting a true partnership approach, Novotech shares a steadfast commitment to client success, empowering innovation, and advancing healthcare worldwide. Recipient of numerous industry accolades, including the Frost & Sullivan CRO Company of the Year award for 19 consecutive years, Novotech is recognized for its excellence in clinical trial execution and innovation. Its deep therapeutic and regulatory expertise, combined with local market insights, ensures streamlined clinical trials, optimized data analytics, and accelerated patient recruitment strategies.
Together with clients, Novotech transforms scientific advancements into therapies that improve global health outcomes, embodying a mission of driving innovation and delivering impactful results.
For more information or to speak to an expert team member visit www.Novotech-CRO.com